Superluminal Medicines

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

• Genesis Therapeutics genesis.mlDirect competitorBoth use AI generative chemistry platforms to design and validate novel small‑molecule therapeutics.
• Exscientia exscientia.comDirect competitorBoth apply AI-driven drug discovery to design and optimize novel small-molecule drug candidates.
• PostEra postera.aiDirect competitorBoth offer AI-powered medicinal chemistry platforms for accelerating small-molecule drug discovery.
• Valence Discovery valencediscovery.comDirect competitorBoth use AI-driven generative molecular design to discover and optimize small-molecule therapeutics.
• Variational AI variational.aiDirect competitorBoth run AI generative platforms to create novel small molecules for early-stage drug discovery.
• PharmCADD pharmcadd.comPartial overlapBoth use AI and modeling of protein–ligand interactions to support small-molecule drug design.
• InterAx Biotech interaxbiotech.comPartial overlapBoth use AI and modeling to design and optimize drugs for GPCR or complex signaling targets.
• Anima Biotech animabiotech.comPartial overlapBoth use AI with experimental biology platforms to discover small-molecule modulators of disease targets.